🇺🇸 FDA
Pipeline program

AntiPlatelet therapy

NFH20190529

Unknown small_molecule active

Quick answer

AntiPlatelet therapy for Coronary Artery Disease is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Coronary Artery Disease
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials